Creative Media & Community Trust Announces Date for Its First Quarter 2025 Earnings Release and Conference Call
A conference call is scheduled for 12:00 p.m. Eastern Time later that day to discuss CMCT's financial results and business. The call will be hosted by Chief Executive Officer David Thompson, Chief Financial Officer Barry Berlin, and Portfolio Oversight Steve Altebrando.
Interested parties can listen to the call via the following:
ABOUT CREATIVE MEDIA & COMMUNITY TRUST CORPORATION
Creative Media & Community Trust Corporation ('CMCT') is a real estate investment trust that owns, operates and develops premier multifamily and creative office assets in vibrant communities throughout the United States. CMCT is a leader in creative office, acquiring and developing properties catering to rapidly growing industries such as technology, media and entertainment. CMCT applies the expertise of CIM to the acquisition, development, and operation of premier multifamily properties situated in dynamic markets with similar business and employment characteristics to its creative office investments. CMCT also owns one hotel in Northern California and a lending platform that originates loans under the Small Business Administration ('SBA')'s 7(a) loan program. CMCT is operated by affiliates of CIM Group, L.P., a vertically-integrated owner and operator of real assets with multi-disciplinary expertise and in-house research, acquisition, credit analysis, development, finance, leasing, and onsite property management capabilities (www.creativemediacommunity.com).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
30 minutes ago
- Yahoo
InMode Ltd.'s (NASDAQ:INMD) Stock Been Rising: Are Strong Financials Guiding The Market?
InMode's (NASDAQ:INMD) stock up by 3.3% over the past month. Since the market usually pay for a company's long-term financial health, we decided to study the company's fundamentals to see if they could be influencing the market. In this article, we decided to focus on InMode's ROE. Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. In simpler terms, it measures the profitability of a company in relation to shareholder's equity. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. How Do You Calculate Return On Equity? Return on equity can be calculated by using the formula: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for InMode is: 28% = US$179m ÷ US$628m (Based on the trailing twelve months to June 2025). The 'return' is the yearly profit. That means that for every $1 worth of shareholders' equity, the company generated $0.28 in profit. View our latest analysis for InMode What Has ROE Got To Do With Earnings Growth? So far, we've learned that ROE is a measure of a company's profitability. Based on how much of its profits the company chooses to reinvest or "retain", we are then able to evaluate a company's future ability to generate profits. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don't share these attributes. InMode's Earnings Growth And 28% ROE To begin with, InMode has a pretty high ROE which is interesting. Additionally, the company's ROE is higher compared to the industry average of 11% which is quite remarkable. Probably as a result of this, InMode was able to see a decent net income growth of 14% over the last five years. As a next step, we compared InMode's net income growth with the industry and found that the company has a similar growth figure when compared with the industry average growth rate of 13% in the same period. Earnings growth is an important metric to consider when valuing a stock. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. Doing so will help them establish if the stock's future looks promising or ominous. What is INMD worth today? The intrinsic value infographic in our free research report helps visualize whether INMD is currently mispriced by the market. Is InMode Efficiently Re-investing Its Profits? Given that InMode doesn't pay any regular dividends to its shareholders, we infer that the company has been reinvesting all of its profits to grow its business. Summary Overall, we are quite pleased with InMode's performance. Particularly, we like that the company is reinvesting heavily into its business, and at a high rate of return. Unsurprisingly, this has led to an impressive earnings growth. That being so, according to the latest industry analyst forecasts, the company's earnings are expected to shrink in the future. Are these analysts expectations based on the broad expectations for the industry, or on the company's fundamentals? Click here to be taken to our analyst's forecasts page for the company. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
30 minutes ago
- Yahoo
Harrow Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
Harrow (NASDAQ:HROW) Second Quarter 2025 Results Key Financial Results Revenue: US$63.7m (up 30% from 2Q 2024). Net income: US$5.00m (up from US$6.47m loss in 2Q 2024). Profit margin: 7.8% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. EPS: US$0.14 (up from US$0.18 loss in 2Q 2024). This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. All figures shown in the chart above are for the trailing 12 month (TTM) period Harrow EPS Beats Expectations, Revenues Fall Short Revenue missed analyst estimates by 3.5%. Earnings per share (EPS) exceeded analyst estimates. Looking ahead, revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the Pharmaceuticals industry in the US. Performance of the American Pharmaceuticals industry. The company's shares are up 13% from a week ago. Balance Sheet Analysis While earnings are important, another area to consider is the balance sheet. We've done some analysis and you can see our take on Harrow's balance sheet. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Here's What Analysts Are Forecasting For Beam Global (NASDAQ:BEEM) After Its Second-Quarter Results
Explore Beam Global's Fair Values from the Community and select yours Beam Global (NASDAQ:BEEM) missed earnings with its latest second-quarter results, disappointing overly-optimistic forecasters. The numbers were fairly weak, with revenue of US$7.1m missing analyst predictions by 2.4%, and (statutory) losses of US$0.28 per share being slightly larger than what the analysts had expected. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Beam Global after the latest results. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. After the latest results, the consensus from Beam Global's five analysts is for revenues of US$32.0m in 2025, which would reflect a small 4.2% decline in revenue compared to the last year of performance. Per-share losses are expected to explode, reaching US$1.61 per share. Yet prior to the latest earnings, the analysts had been forecasting revenues of US$32.4m and losses of US$1.63 per share in 2025. See our latest analysis for Beam Global As a result there was no major change to the consensus price target of US$3.50, implying that the business is trading roughly in line with expectations despite ongoing losses. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. Currently, the most bullish analyst values Beam Global at US$4.00 per share, while the most bearish prices it at US$3.00. The narrow spread of estimates could suggest that the business' future is relatively easy to value, or thatthe analysts have a strong view on its prospects. Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. We would highlight that revenue is expected to reverse, with a forecast 8.2% annualised decline to the end of 2025. That is a notable change from historical growth of 42% over the last five years. By contrast, our data suggests that other companies (with analyst coverage) in the same industry are forecast to see their revenue grow 9.4% annually for the foreseeable future. It's pretty clear that Beam Global's revenues are expected to perform substantially worse than the wider industry. The Bottom Line The most important thing to take away is that the analysts reconfirmed their loss per share estimates for next year. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Beam Global's revenue is expected to perform worse than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates. With that in mind, we wouldn't be too quick to come to a conclusion on Beam Global. Long-term earnings power is much more important than next year's profits. At Simply Wall St, we have a full range of analyst estimates for Beam Global going out to 2027, and you can see them free on our platform here.. That said, it's still necessary to consider the ever-present spectre of investment risk. We've identified 5 warning signs with Beam Global (at least 1 which is concerning) , and understanding them should be part of your investment process. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
